Clinical Trial Update: Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen [NA]

View source ↗

Summary

Completed clinical trial comparing photodynamic therapy (verteporfin), intravitreal ranibizumab, and their combination for polypoidal choroidal vasculopathy und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Ranibizumab (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Polypoidal Choroidal Vasculopathy | NA | Status: COMPLETED